AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24898221 — intervention group
Group type: EXPERIMENTAL
Intervention: At-home bleaching system (Opalescence PF 35% Carbamide Peroxide, Ultradent)
Number of subjects: 28
Study 24898221 — intervention group
Group type: COMPARATOR
Intervention: Chemically activated office bleaching system (Opalescence Xtra Boost 38% Hydrogen Peroxide, Ultradent)
Number of subjects: 28
Study 23402714 — intervention group
Group type: EXPERIMENTAL
Intervention: Overfed (OF)
Number of subjects: 58
Study 23402714 — intervention group
Group type: EXPERIMENTAL
Intervention: Underfed (UF)
Number of subjects: 58
Study 23402714 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese-prone (OP)
Number of subjects: 58
Study 23402714 — intervention group
Group type: COMPARATOR
Intervention: Eucaloric (EU)
Number of subjects: 58
Study 22320068 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified fluoride toothpaste technique (n = 56)
Number of subjects: 175
Study 22320068 — intervention group
Group type: COMPARATOR
Intervention: Regular fluoride toothpaste (Control group, n = 57)
Number of subjects: 175
Study 19825059 — intervention group
Group type: EXPERIMENTAL
Intervention: Auto-control mode
Number of subjects: 80
Study 19825059 — intervention group
Group type: COMPARATOR
Intervention: Manual control
Number of subjects: 80
Study 16428521 — intervention group
Group type: EXPERIMENTAL
Intervention: Miniaturized bypass systems (SBS)
Number of subjects: 45
Study 16428521 — intervention group
Group type: COMPARATOR
Intervention: Conventional CPB (cCPB)
Number of subjects: 45
Study 15509922 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous rhinoplasty
Number of subjects: 412
Study 15509922 — intervention group
Group type: COMPARATOR
Intervention: Conventional method
Number of subjects: 412
Study 11387364 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 Gy total fractionated dose for the clinically noninvolved extended field (arm A)
Number of subjects: 376
Study 11387364 — intervention group
Group type: COMPARATOR
Intervention: 30 Gy total fractionated dose for the clinically noninvolved extended field (arm B)
Number of subjects: 376
Study 9407458 — intervention group
Group type: EXPERIMENTAL
Intervention: cilazapril (2 mg/day)
Number of subjects: 10
Study 7714164 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 or 400 mg RU486 administered on day LH+2
Number of subjects: 11
Study 7714164 — intervention group
Group type: COMPARATOR
Intervention: Control group (no RU486 treatment)
Number of subjects: 11
Study 2967936 — intervention group
Group type: EXPERIMENTAL
Intervention: Duovent (fenoterol 0.1 mg/ipratropium 0.04 mg per puff)
Number of subjects: 30
Study 2967936 — intervention group
Group type: EXPERIMENTAL
Intervention: Duovent (2 puffs)
Number of subjects: 30
Study 2967936 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol (0.1 mg per puff)
Number of subjects: 30
Study 2967936 — intervention group
Group type: EXPERIMENTAL
Intervention: Duovent (1, 2, and 4 puffs)
Number of subjects: 30
Study 2967936 — intervention group
Group type: EXPERIMENTAL
Intervention: Duovent and Salbutamol
Number of subjects: 30
Study 30707211 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid cycle deliberate practice
Number of subjects: 46
Study 30707211 — intervention group
Group type: COMPARATOR
Intervention: Reflective debriefing
Number of subjects: 46
Study 29141041 — intervention group
Group type: EXPERIMENTAL
Intervention: Berry beverage (150g blueberries, 50g blackcurrant, 50g elderberry, 50g lingonberries, 50g strawberry, and 100g tomatoes)
Number of subjects: 40
Study 29141041 — intervention group
Group type: COMPARATOR
Intervention: Control beverage (water based, matched with respect to monosaccharides, pH, and volume)
Number of subjects: 40
Study 26691360 — intervention group
Group type: EXPERIMENTAL
Intervention: Harmonic scalpel
Number of subjects: 80
Study 26691360 — intervention group
Group type: COMPARATOR
Intervention: Electrocautery
Number of subjects: 80
Study 23334780 — intervention group
Group type: EXPERIMENTAL
Intervention: Obturator and lateral femoral cutaneous nerve blockade
Number of subjects: 1422
Study 23334780 — intervention group
Group type: EXPERIMENTAL
Intervention: Fascia iliaca blockade
Number of subjects: 1422
Study 23334780 — intervention group
Group type: COMPARATOR
Intervention: Other nerve blocks
Number of subjects: 1422
Study 21975318 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant HAI‐FUDR plus dexamethasone (Dex) and concurrent systemic chemotherapy including oxaliplatin or irinotecan
Number of subjects: 125
Study 21975318 — intervention group
Group type: COMPARATOR
Intervention: Modern systemic chemotherapy alone
Number of subjects: 125
Study 18471455 — intervention group
Group type: EXPERIMENTAL
Intervention: Stopped exercise before achieving 85% of age-specific maximal HR
Number of subjects: 12555
Study 18471455 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased HR at rest
Number of subjects: 12555
Study 18471455 — intervention group
Group type: EXPERIMENTAL
Intervention: Attenuated HR increase
Number of subjects: 12555
Study 18471455 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed HR recovery
Number of subjects: 12555
Study 18471455 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise duration
Number of subjects: 12555
Study 16436175 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrow band ultraviolet B (NB UVB 311 nm)
Number of subjects: 35
Study 16436175 — intervention group
Group type: COMPARATOR
Intervention: Psoralen ultraviolet A (PUVA)
Number of subjects: 35
Study 16436175 — intervention group
Group type: COMPARATOR
Intervention: Psoralen followed by narrow band ultraviolet B (PUVB 311 nm)
Number of subjects: 35
Study 15909609 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructose 1.6-diphosphate (FDP) administered i.v. for 7 consecutive days
Number of subjects: 17
Study 11352361 — intervention group
Group type: EXPERIMENTAL
Intervention: m-chlorophenylpiperazine (mCPP)
Number of subjects: 0
Study 11352361 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 9845400 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg octreotide acetate
Number of subjects: 2102
Study 9845400 — intervention group
Group type: COMPARATOR
Intervention: Isotonic sodium chloride (control)
Number of subjects: 2102
Study 7925785 — intervention group
Group type: EXPERIMENTAL
Intervention: Movements in the 30 degrees direction
Number of subjects: 0
Study 7925785 — intervention group
Group type: COMPARATOR
Intervention: Movements in the 150 degrees direction
Number of subjects: 0
Study 7925785 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated accelerations in 24 directions
Number of subjects: 0
Study 7925785 — intervention group
Group type: EXPERIMENTAL
Intervention: Actual accelerations produced by subjects
Number of subjects: 0
Study 2513207 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard metrifonate treatment (3 doses of 7.5 mg.kg‐1 at two‐weekly intervals)
Number of subjects: 300
Study 2513207 — intervention group
Group type: EXPERIMENTAL
Intervention: Abbreviated metrifonate treatment (3 doses of 5 mg.kg‐1 in one day)
Number of subjects: 300
Study 31241404 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery (MIS)
Number of subjects: 252
Study 26849366 — intervention group
Group type: EXPERIMENTAL
Intervention: Human body posturizer (HBP)
Number of subjects: 150
Study 26849366 — intervention group
Group type: COMPARATOR
Intervention: Physical training without HBP (exercise group)
Number of subjects: 150
Study 25220909 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine pericardium membrane placed over the graft
Number of subjects: 26
Study 25220909 — intervention group
Group type: COMPARATOR
Intervention: No membrane placed over the graft (Control)
Number of subjects: 26
Study 22898035 — intervention group
Group type: EXPERIMENTAL
Intervention: BIIB021 600 mg twice a week (BIW)
Number of subjects: 23
Study 22898035 — intervention group
Group type: EXPERIMENTAL
Intervention: BIIB021 400 mg three times a week (TIW)
Number of subjects: 23
Study 22898035 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall response rate with BIIB021
Number of subjects: 23
Study 22040618 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokeless Tobacco Educational Unit (STEU)
Number of subjects: 0
Study 22040618 — intervention group
Group type: EXPERIMENTAL
Intervention: Information-Motivation-Behavioral Skills model (IMB model)
Number of subjects: 0
Study 19632547 — intervention group
Group type: EXPERIMENTAL
Intervention: Argentine tango dance lessons (10 sessions of 1.5 hours each over 2 weeks)
Number of subjects: 14
Study 16314381 — intervention group
Group type: EXPERIMENTAL
Intervention: Outcome realizations at 6 months
Number of subjects: 118
Study 16314381 — intervention group
Group type: EXPERIMENTAL
Intervention: High expectations but low attainment
Number of subjects: 118
Study 16314381 — intervention group
Group type: EXPERIMENTAL
Intervention: High attainment, regardless of expectations
Number of subjects: 118
Study 15351416 — intervention group
Group type: EXPERIMENTAL
Intervention: Templating system for ALPHANORM unicondylar knee prosthesis
Number of subjects: 29
Study 11527645 — intervention group
Group type: EXPERIMENTAL
Intervention: GTN (0.6 mg/h/24 h)
Number of subjects: 30
Study 11527645 — intervention group
Group type: EXPERIMENTAL
Intervention: PETN (60 mg orally three times a day)
Number of subjects: 30
Study 11527645 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 30
Study 9419950 — intervention group
Group type: EXPERIMENTAL
Intervention: UDCA 600 mg per day
Number of subjects: 38
Study 9419950 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 8513925 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial zona dissection
Number of subjects: 199
Study 8513925 — intervention group
Group type: COMPARATOR
Intervention: Conventional IVF
Number of subjects: 199
Study 2820289 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternating chemotherapy (cyclophosphamide, doxorubicin, vincristine alternating with etoposide (100 mg/m2 on days 1 to 3) and cisplatin (25 mg/m2 on days 1 to 3) every 3 weeks for six treatment cycles)
Number of subjects: 289
Study 2820289 — intervention group
Group type: COMPARATOR
Intervention: Standard chemotherapy (cyclophosphamide (1000 mg/m2), doxorubicin (50 mg/m2), and vincristine (2 mg) every 3 weeks for six courses)
Number of subjects: 289
Study 2820289 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternating chemotherapy
Number of subjects: 289
Study 2820289 — intervention group
Group type: COMPARATOR
Intervention: Standard chemotherapy
Number of subjects: 289
Study 30374055 — intervention group
Group type: EXPERIMENTAL
Intervention: Testing for immunoglobulin M (IgM) and G (IgG) responses against 20 microbes associated with TBD
Number of subjects: 432
Study 30374055 — intervention group
Group type: EXPERIMENTAL
Intervention: Testing for Borrelia and other related TBD microbes
Number of subjects: 432
Study 26799451 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 25% sodium metabisulfite
Number of subjects: 4
Study 25792583 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients undergoing dialysis
Number of subjects: 53
Study 25792583 — intervention group
Group type: COMPARATOR
Intervention: Control group (N=25)
Number of subjects: 53
Study 23852652 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampicin
Number of subjects: 2
Study 23852652 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole
Number of subjects: 2
Study 23852652 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole
Number of subjects: 2
Study 23852652 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 2
Study 19940781 — intervention group
Group type: EXPERIMENTAL
Intervention: American Gastroenterological Association colonoscopy educational pamphlet (group I)
Number of subjects: 106
Study 19940781 — intervention group
Group type: COMPARATOR
Intervention: Standard prep instructions only (group P)
Number of subjects: 106
Study 18501650 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized arformoterol (15 microg)
Number of subjects: 39
Study 18501650 — intervention group
Group type: COMPARATOR
Intervention: Racemic formoterol DPI (12 microg)
Number of subjects: 39
Study 18501650 — intervention group
Group type: COMPARATOR
Intervention: Racemic formoterol DPI (24 microg)
Number of subjects: 39
Study 16034446 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 30 mg
Number of subjects: 9
Study 16034446 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine (ATX) 60 mg
Number of subjects: 9
Study 14512180 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.2 mg/kg/day start, tapering doses)
Number of subjects: 36
Study 14512180 — intervention group
Group type: COMPARATOR
Intervention: Placebo (equivalent amounts of normal saline)
Number of subjects: 36
Study 11022398 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptophan (2 to 4 g per day) with fluoxetine (20 mg per day)
Number of subjects: 30
Study 11022398 — intervention group
Group type: COMPARATOR
Intervention: Placebo with fluoxetine (20 mg per day)
Number of subjects: 30
Study 8774267 — intervention group
Group type: EXPERIMENTAL
Intervention: Open cholecystectomy
Number of subjects: 0
Study 8774267 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 0
Study 8774267 — intervention group
Group type: COMPARATOR
Intervention: Insulin
Number of subjects: 0
Study 1321490 — intervention group
Group type: EXPERIMENTAL
Intervention: 1:200,000 epinephrine in a four percent articaine‐HCl solution
Number of subjects: 0
Study 1321490 — intervention group
Group type: EXPERIMENTAL
Intervention: 1:100,000 epinephrine in a four percent articaine‐HCl solution
Number of subjects: 0
Study 1321490 — intervention group
Group type: COMPARATOR
Intervention: Volunteers injected without subsequent operation (control group)
Number of subjects: 0
Study 6514177 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirlindole
Number of subjects: 0
Study 6514177 — intervention group
Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 0
Study 6514177 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirlindole with ethanol (0.4 g 17 vol%/kg)
Number of subjects: 0
Study 6514177 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31618073 — intervention group
Group type: EXPERIMENTAL
Intervention: Hop-stabilization training program (6 weeks, 18 training sessions)
Number of subjects: 28
Study 29167910 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified CPR training
Number of subjects: 85
Study 29167910 — intervention group
Group type: COMPARATOR
Intervention: Standard CPR training
Number of subjects: 85
Study 26868318 — intervention group
Group type: EXPERIMENTAL
Intervention: Curved laparoscopic instruments (Group-C)
Number of subjects: 20
Study 26868318 — intervention group
Group type: EXPERIMENTAL
Intervention: Straight laparoscopic instruments (Group-S)
Number of subjects: 20
Study 26868318 — intervention group
Group type: COMPARATOR
Intervention: Curved instruments (after swapping) for Group-S
Number of subjects: 20
Study 26868318 — intervention group
Group type: COMPARATOR
Intervention: Straight instruments (after swapping) for Group-C
Number of subjects: 20
Study 24551029 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic low dose penicillin V (6 months for first episode, 12 months for recurrent cellulitis)
Number of subjects: 397
Study 24551029 — intervention group
Group type: COMPARATOR
Intervention: Prophylactic low dose penicillin V
Number of subjects: 397
Study 21760585 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotenoid supplementation (lutein, lycopene, β‐carotene)
Number of subjects: 203
Study 20118492 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin 80 mg once daily
Number of subjects: 44
Study 20118492 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (PEG-IFN-alpha 2b and ribavirin)
Number of subjects: 44
Study 18057337 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking for 2 hours on Oxford Street
Number of subjects: 60
Study 18057337 — intervention group
Group type: COMPARATOR
Intervention: Walking for 2 hours in Hyde Park
Number of subjects: 60
Study 18057337 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure on Oxford Street
Number of subjects: 60
Study 15642859 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone (0.75 mg/kg daily for the first 10 days of each month for 6 months)
Number of subjects: 17
Study 15642859 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.75 mg/kg daily for the first 10 days of each month for 6 months)
Number of subjects: 17
Study 11851640 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured counselling and follow-up (Intervention group, n = 38)
Number of subjects: 76
Study 11851640 — intervention group
Group type: COMPARATOR
Intervention: Standard advice sheet and referral to GP (Control group, n = 38)
Number of subjects: 76
Study 11851640 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori eradicated patients
Number of subjects: 76
Study 11851640 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori persistent patients
Number of subjects: 76
Study 11284774 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 0
Study 9307912 — intervention group
Group type: EXPERIMENTAL
Intervention: Localized 31P MR spectroscopy in transplant kidneys with rejection
Number of subjects: 37
Study 9307912 — intervention group
Group type: EXPERIMENTAL
Intervention: Localized 31P MR spectroscopy in transplant kidneys with tubular necrosis
Number of subjects: 37
Study 9307912 — intervention group
Group type: EXPERIMENTAL
Intervention: pH measurement in transplant kidneys with rejection
Number of subjects: 37
Study 9307912 — intervention group
Group type: EXPERIMENTAL
Intervention: pH measurement in transplant kidneys with tubular necrosis
Number of subjects: 37
Study 9307912 — intervention group
Group type: COMPARATOR
Intervention: Control group (patients with no evidence of transplant dysfunction)
Number of subjects: 37
Study 8384278 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg Lomefloxacin (200 mg b.i.d.)
Number of subjects: 122
Study 8384278 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg Lomefloxacin (200 mg t.i.d.)
Number of subjects: 122
Study 3700344 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline 50 mg
Number of subjects: 15
Study 3700344 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone 100 mg
Number of subjects: 15
Study 3700344 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 29407689 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate exercise group (MEG; 40-68% of heart rate reserve) for 10min
Number of subjects: 110
Study 29407689 — intervention group
Group type: COMPARATOR
Intervention: Passive sitting group (PSG)
Number of subjects: 110
Study 26707054 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual multimodal screening (MMS)
Number of subjects: 202546
Study 26707054 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual transvaginal ultrasound screening (USS)
Number of subjects: 202546
Study 26707054 — intervention group
Group type: COMPARATOR
Intervention: No screening (Control)
Number of subjects: 202546
Study 26707054 — intervention group
Group type: COMPARATOR
Intervention: MMS vs No screening (excluding prevalent cases)
Number of subjects: 202546
Study 25193943 — intervention group
Group type: EXPERIMENTAL
Intervention: Painful experiences (ice water immersion, leg squats)
Number of subjects: 0
Study 25193943 — intervention group
Group type: EXPERIMENTAL
Intervention: Painful experiences (hot chili pepper)
Number of subjects: 0
Study 25193943 — intervention group
Group type: COMPARATOR
Intervention: No-pain control treatment
Number of subjects: 0
Study 23972415 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback intervention for experimental group patients using the OQ-45 total scale
Number of subjects: 43
Study 23972415 — intervention group
Group type: COMPARATOR
Intervention: Control group (treatment-as-usual)
Number of subjects: 43
Study 23972415 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback intervention for experimental group patients
Number of subjects: 43
Study 23972415 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group patients
Number of subjects: 43
Study 20613472 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (2 microg/ml)
Number of subjects: 14
Study 20613472 — intervention group
Group type: COMPARATOR
Intervention: 10% Intralipid
Number of subjects: 14
Study 20613472 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 14
Study 19024258 — intervention group
Group type: EXPERIMENTAL
Intervention: Brushed machined surfaces
Number of subjects: 8
Study 19024258 — intervention group
Group type: EXPERIMENTAL
Intervention: Brushed plasma sprayed surfaces
Number of subjects: 8
Study 19024258 — intervention group
Group type: COMPARATOR
Intervention: Non-brushed machined surfaces
Number of subjects: 8
Study 19024258 — intervention group
Group type: EXPERIMENTAL
Intervention: Machined surfaces
Number of subjects: 8
Study 19024258 — intervention group
Group type: COMPARATOR
Intervention: Non-brushed surfaces
Number of subjects: 8
Study 19024258 — intervention group
Group type: EXPERIMENTAL
Intervention: Brushed surfaces
Number of subjects: 8
Study 19024258 — intervention group
Group type: EXPERIMENTAL
Intervention: Implant brushing on machined surfaces
Number of subjects: 8
Study 16616656 — intervention group
Group type: EXPERIMENTAL
Intervention: dopexamine (2 microg/kg/min, n = 20)
Number of subjects: 61
Study 16616656 — intervention group
Group type: EXPERIMENTAL
Intervention: dopamine (3 microg/kg/min, n = 21)
Number of subjects: 61
Study 16616656 — intervention group
Group type: COMPARATOR
Intervention: placebo (n = 20)
Number of subjects: 61
Study 12647006 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratunical instillation of 2.5 mL of 0.5 % bupivacaine combined with 10 mg/ml methylprednisolone
Number of subjects: 65
Study 12647006 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving only analgesics postoperatively by intramuscular route
Number of subjects: 65
Study 11004352 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethyl icosapentate 1800 mg daily and estriol (E3) 2 mg daily (eicosapentaenoic acid group, n = 69)
Number of subjects: 141
Study 11004352 — intervention group
Group type: COMPARATOR
Intervention: Estriol (E3) 2 mg daily (control group, n = 72)
Number of subjects: 141
Study 8976475 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal manipulative therapy (SMT) combined with trunk strengthening exercises (TSE)
Number of subjects: 174
Study 8976475 — intervention group
Group type: COMPARATOR
Intervention: Spinal manipulative therapy (SMT) combined with trunk stretching exercises
Number of subjects: 174
Study 8976475 — intervention group
Group type: COMPARATOR
Intervention: Nonsteroidal anti-inflammatory drug (NSAID) therapy combined with trunk strengthening exercises (TSE)
Number of subjects: 174